Health Catalyst financials
$1.75−1.13%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70.5M | $70.8M | $74.7M | $76.3M | $80.7M | $79.4M | $79.6M | $76.4M | $75.9M | $74.7M | $75.1M | $73.8M |
| Gross profit | $34.9M | $35.5M | $39.4M | $37.8M | $38.2M | $36.2M | $34.7M | $34.0M | $35.8M | $36.2M | $30.5M | $32.0M |
| Gross margin | 49.5% | 50.1% | 52.7% | 49.5% | 47.4% | 45.6% | 43.6% | 44.6% | 47.2% | 48.5% | 40.6% | 43.4% |
| Operating income | -$36.5M | -$106.5M | -$86.1M | -$17.5M | -$37.1M | -$20.2M | -$17.5M | -$13.7M | -$15.8M | -$22.8M | -$32.8M | -$24.6M |
| Net income | -$40.5M | -$111.0M | -$91.0M | -$22.2M | -$41.0M | -$23.7M | -$20.7M | -$14.7M | -$13.5M | -$20.6M | -$30.3M | -$22.0M |
| Net margin | −57.5% | −156.9% | −121.9% | −29.1% | −50.8% | −29.9% | −26.0% | −19.3% | −17.8% | −27.6% | −40.4% | −29.9% |
| Diluted EPS | $-0.55 | $-1.53 | $-1.28 | $-0.32 | $-0.59 | $-0.35 | $-0.33 | $-0.24 | $-0.23 | $-0.35 | $-0.53 | $-0.39 |
| EBITDA | $1.5M | $1.1M | $8.3M | -$4.9M | $4.4M | -$7.9M | -$7.2M | -$3.7M | -$5.2M | -$12.3M | -$32.8M | -$14.4M |
| Operating cash flow | $275.0K | $18.5M | $9.9M | -$464.0K | -$9.0M | $280.0K | -$3.5M | $6.2M | $1.6M | $10.3M | -$19.0M | $3.1M |
| Free cash flow | -$70.0K | $18.2M | $9.6M | -$719.0K | -$9.2M | -$390.0K | -$3.9M | $5.5M | $1.3M | $10.1M | -$19.3M | $3.0M |
| Diluted shares | 74.0M | 72.6M | 71.0M | 70.4M | 69.6M | 68.6M | 62.4M | 60.4M | 59.3M | 58.6M | 57.5M | 56.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $60.6M | $59.9M | $50.8M | $40.3M | $50.7M | $342.0M |
| Short-term investments | $42.9M | $49.0M | $44.9M | $51.2M | $46.6M | $0.00 |
| Total debt | $153.5M | $153.4M | $153.3M | $153.1M | $153.0M | $382.9M |
| Total assets | $358.6M | $412.2M | $502.6M | $587.1M | $616.2M | $891.5M |
| Total liabilities | $257.8M | $274.1M | $256.9M | $255.2M | $268.6M | $514.7M |
| Shareholders' equity | $100.8M | $138.1M | $245.8M | $331.9M | $347.5M | $376.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology